L564-0345 Screening compound: N-(1-benzylpiperidin-4-yl)-3-[2-(3-methoxyphenoxy)pyrimidin-5-yl]benzamide

L564-0345 Screening compound: N-(1-benzylpiperidin-4-yl)-3-[2-(3-methoxyphenoxy)pyrimidin-5-yl]benzamide
L564-0345 Screening compound: N-(1-benzylpiperidin-4-yl)-3-[2-(3-methoxyphenoxy)pyrimidin-5-yl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L564-0345
N-(1-benzylpiperidin-4-yl)-3-[2-(3-methoxyphenoxy)pyrimidin-5-yl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L564-0345

Molecular Formula

C30H30N4O3 (C30 H30 N4 O3)

Compound Name

N-(1-benzylpiperidin-4-yl)-3-[2-(3-methoxyphenoxy)pyrimidin-5-yl]benzamide

IUPAC name

N-(1-benzylpiperidin-4-yl)-3-[2-(3-methoxyphenoxy)pyrimidin-5-yl]benzamide

SMILES

COc1cccc(Oc(nc2)ncc2-c2cccc(C(NC3CCN(Cc4ccccc4)CC3)=O)c2)c1

InChI

InChI=1S/C30H30N4O3/c1-36-27-11-6-12-28(18-27)37-30-31-19-25(20-32-30)23-9-5-10-24(17-23)29(35)33-26-13-15-34(16-14-26)21-22-7-3-2-4-8-22/h2-12,17-20,26H,13-16,21H2,1H3,(H,33,35)

InChI Key

PMIOIOIJTJPZRP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27462447

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

494.59

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.753

Distribution Coefficient, logD

3.308

Water Solubility, LogSw

-4.48

Polar Surface Area

61.353

Acid Dissociation Constant (pKa)

15.32

Base Dissociation Constant (pKb)

8.83

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.30

L564-0345 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L564-0345 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L564-0345?
Check Price and Availability of L564-0345, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L564-0345 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L564-0345
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L564-0345
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L564-0345 available by request